Dyne Therapeutics, Inc. Targets IPO to Power Next-Generation Muscle Disease Treatments
Dyne Therapeutics, Inc. (DYN), a clinical-stage biotechnology firm specializing in treatments for rare neuromuscular diseases, is preparing for a public offering aimed at accelerating...
Avidity Biosciences, Inc. Plans $600 Million IPO to Advance RNA Therapeutics for Rare Genetic Diseases
Avidity Biosciences, Inc. (RNA), a San Diego–based biotechnology company pioneering antibody oligonucleotide conjugates (AOCs), is preparing for a $600 million initial public offering (IPO)...
Merck & Co., Inc. Eyes $5 Billion Spin-Off IPO to Accelerate Oncology and Vaccine Innovation
Merck & Co., Inc. (MRK), one of the world’s leading pharmaceutical giants, is preparing for a $5 billion initial public offering (IPO) of its...
Visa Inc. Announces Landmark Secondary IPO to Expand Digital Payments Network Amid Fintech Surge
Visa Inc. (V), the global payments leader, has announced plans for a secondary stock offering in early 2026, aiming to raise up to $2.5...
Fluence Energy, Inc. Targets $850 Million IPO to Accelerate Global Renewable Storage Expansion
Fluence Energy, Inc. (FLNC), a leading provider of energy storage systems and renewable optimization software, is gearing up for a major initial public offering...
